 |
인쇄하기
취소
|
Lilly, market launching of Strattera for ADHD treatment.
Lilly Korea announced market launching of Strattera (atomoxetine), an ADHD therapeutic drug, having 24 hour sustained activity by once a day administration.
Strattera (atomoxetine), a new non-stimulant drug to treat ADHD in adults and children over age 6 is a selective norepinephrine reuptake inhibitor with comparatively less drug abuse, and resistance features than the existing ADHD drugs....
Strattera (atomoxetine), a new non-stimulant drug to treat ADHD in adults and children over age 6 is a selective norepinephrine reuptake inhibitor with comparatively less drug abuse, and resistance features than the existing ADHD drugs....
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.